Journal of Contemporary Brachytherapy
eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Share:
Send email
Share:
abstract:
Original paper

Efficacy of peri-operative high-dose-rate interstitial brachytherapy in keloids: Can we scare the bad scar?

Kilaru Sneha
1
,
Ayesha Iqbal Maniyar
1
,
Lithika Lavanya
1
,
Kirthi Koushik
2
,
Ram Charith Alva
3
,
Janaki Gururajachar Manur
1
,
Arul Ponni T.R.
1
,
Mohan Kumar S.
1
,
Revathy Periyasamy
1

  1. Ramaiah Medical College Hospital, Bangalore, India
  2. HCG Cancer Hospital, Bangalore, India
  3. Aster CMI Hospital, Bangalore, India
J Contemp Brachytherapy 2026
DOI: https://doi.org/10.5114/jcb.2026.161350
Online publish date: 2026/04/28
View full text Get citation
 
Purpose
Keloids arise from dysregulated wound healing, characterized by excessive fibroblast activity and collagen deposition. Despite multiple treatment modalities, recurrence rates after excision remain high. High-dose-rate (HDR) brachytherapy delivers localized radiation, minimizing exposure to surrounding structures. This study evaluated clinical outcomes and dosimetric parameters in patients undergoing surgical excision followed by peri-operative HDR brachytherapy for keloid management at a single institution.

Material and methods
In this retrospective analysis, 32 patients treated over the past 6 years who underwent scar excision and immediate peri-operative brachytherapy to a dose of 15 Gy in 3 fractions, were analyzed. Outcomes, including recurrence, acute reactions, delayed wound healing, and late pigmentary or cosmetic changes, were assessed via telephonic interviews, while no direct clinical examination was performed. Dosimetric parameters (treatment length, volume, V100%, V150%, and V200%) were recorded for 24 patients with retrievable simulation scans. Statistical associations between patient-treatment variables and recurrence were assessed.

Results
The study comprised 17 males and 15 females (median age, 33 years; range, 21-65 years). Keloid sites included the ear (50%), chest (40.6%), extremities (6.3%), and scapula (3.1%). Median length treated and volume were 3.75 cm and 1.7 cm3, respectively; mean V100% was 91.15% (±4.87), and V200% was 26.71% (±7.99). At a median follow-up of 25 months, four patients (12.5%) experienced recurrence. No significant associations were found between recurrence and sex, lesion site, etiologic cause, prior treatment, age, treatment length or volume, or dosimetric parameters (all p > 0.05). Acute and late toxicities were minimal, with only one case of transient paraesthesia, and no reported secondary malignancies.

Conclusions
Surgical excision and immediate peri-operative brachytherapy can be considered in the first occurrence of keloid. Attention should be paid to interval between surgery and radiotherapy (RT) start, and to the dosimetric optimization of RT treatment.

keywords:

benign, recurrence, keloid, HDR, brachytherapy, cosmesis, peri-operative

  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Termedia.